Bleichroeder Acquisition Corp. II shareholders approve Pasqal combination, 21,467,865 votes in favor
NEW YORK, Aug 25. With 21,467,865 votes cast in favor and 2,616,196 against, Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ) shareholders approved a business combination with Pasqal Holding SAS at an extraordinary general meeting held August 25, 2026, the company disclosed in an 8-K. Pasqal is a French société par actions simplifiée. The deal cleared.
Key takeaways
- Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ) shareholders approved a business combination with France's Pasqal Holding SAS on August 25, 2026, with 21,467,865 votes in favor and 2,616,196 against.
- A quorum of 24,086,739 ordinary shares, or 62.83% of total shares outstanding, was present at the extraordinary general meeting.
- Related proposals including the Reincorporation Merger, the French Merger Agreement, six advisory governing-documents sub-proposals, and three equity incentive plans all passed.
- Dr. Wasiq Bokhari, named to the incoming Pasqal board, was elected with 21,470,546 votes in favor.
- Bleichroeder disclosed the results in an 8-K filed as a Rule 425 written communication under File No. 333-296239.
NEW YORK, Aug 25. With 21,467,865 votes cast in favor and 2,616,196 against, Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ) shareholders approved a business combination with Pasqal Holding SAS at an extraordinary general meeting held August 25, 2026, the company disclosed in an 8-K. Pasqal is a French société par actions simplifiée. The deal cleared.
A quorum of 24,086,739 ordinary shares, or 62.83% of total shares outstanding, was present at the meeting either in person or by proxy. As of August 4, 2026, the record date, Bleichroeder had 38,333,333 ordinary shares issued and outstanding: 28,750,000 Class A shares at par value $0.0001 and 9,583,333 Class B shares at the same par value.
The Reincorporation Merger Proposal passed by the same margin: 21,467,865 in favor, 2,616,196 against, 2,788 abstentions. The French Merger Agreement proposal, covering the direct merger with Pasqal, received 21,466,490 votes for and 2,615,896 against, with 4,463 abstentions.
Six advisory, non-binding governing documents sub-proposals each passed. Tallies varied; the narrowest drew 20,367,913 in favor against 3,715,848 opposed.
The meeting also approved three equity incentive instruments tied to the transaction: the 2026 Restricted Stock Units Plan, the 2026 Founder Share Subscription Warrants program, and the 2026 Stock Option Program. Shareholders additionally approved a delegation of authority to issue warrants described in the filing as bons de souscription d'actions.
The Director Election Proposal passed. Dr. Wasiq Bokhari, named to the incoming Pasqal board, received 21,470,546 votes in favor, the filing shows.
The 8-K was filed simultaneously as a written communication under Rule 425 of the Securities Act, File No. 333-296239. The company's definitive proxy statement and prospectus was dated August 5, 2026; a supplement followed August 14, 2026.
Bleichroeder Acquisition Corp. II is incorporated in the Cayman Islands and holds principal offices at 1345 Avenue of the Americas, Floor 47, New York. Units trade on Nasdaq under BBCQU. Redeemable warrants, each exercisable for one Class A ordinary share at $11.50 per share, trade under BBCQW.